Iovance Biotherapeutics Inc Sustainability Reports
Iovance Biotherapeutics, Inc. is a biotechnology company focused on innovating, developing, and commercializing autologous tumor-infiltrating lymphocyte (TIL) cell therapies for patients with cancer.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 2549002L8WT2ACU5Q878
FIGI: BBG001T2PM32
3 reports from 2018 to 2024
